One bottle of heavyweight new drug approved for 100000 yuan! How much impact will the soaring stock price have?
Ty奇葩罗牛山831
发表于 2024-3-28 15:18:59
1203
0
0
On March 26th, US pharmaceutical giant Merck announced that its new drug for treating a deadly lung disease has been approved by the US Food and Drug Administration (FDA). Affected by this, the US stock market closed overnight, and Merck's stock price surged nearly 5%, reaching a historic high. The latest total market value rose to $333.7 billion (approximately RMB 2400 billion). The drug is marketed as Winrevair and is used to treat pulmonary arterial hypertension (PAH). Each bottle is priced at up to $14000 (approximately RMB 100000), and the annual cost is as high as $242000 (approximately RMB 1.74 million). Wall Street analysts are optimistic that Winrevair's annual sales may reach as high as $7.5 billion (approximately RMB 54 billion).
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Heavy weight late at night! The fourth test flight of the Starship has been successful! Musk: A tremendous achievement
- JD's "Spring Dawn Plan" Heavily Upgrades and Launches 12 New Support Measures, Merchant Live Streaming Can Get 5000 Traffic Coupons
- US heavyweight data released: Will gold and silver plummet and cut interest rates this year?
- How much impact did Intel's performance fall short of expectations have? Industrial Fulian responds
- The Bank of Japan sends a heavy signal! There are still reasons to raise interest rates again
- Putin speaks up! What is the impact of Russia or restrictions on strategic raw material exports?
- Heavy weight! JD is expected to open Alipay payment
- Meta releases heavyweight new products: $299 Quest 3S headset, AR glasses prototype, multimodal AI model
- It concerns the pricing benchmark for heavyweight interest rates! The third in command of the Federal Reserve announced the establishment of a new institution
- Heavy weight! Microsoft releases 10 AI agents with the support of O1
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 前天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 昨天 17:41
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 昨天 16:27
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 昨天 14:41
- 支持
- 反对
- 回复
- 收藏